T3 N1 M0 rectal cancer: optimal initial management is total neoadjuvant therapy

被引：0
作者：
Nilsson, Per J. [1 ,2 ]
机构：
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Inst, Dept Mol Med & Surg, Euegeniav 6, Hotellet pl 2, SE-17176 Stockholm, Sweden
来源：
BRITISH JOURNAL OF SURGERY | 2024年 / 111卷 / 01期
关键词：
PREOPERATIVE CHEMORADIOTHERAPY; OPEN-LABEL; CHEMOTHERAPY;
D O I：
10.1093/bjs/znad322
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Total Neoadjuvant Therapy With PD-1 Blockade for High-Risk Proficient Mismatch Repair Rectal Cancer
    Li, Yingjie
    Pan, Chaohu
    Gao, Yuye
    Zhang, Li
    Ji, Dengbo
    Cui, Xiaoli
    Zhang, Xiaoyan
    Cai, Yong
    Zhang, Yangzi
    Yao, Yunfeng
    Wang, Lin
    Leng, Jiahua
    Zhan, Tiancheng
    Wu, Dongfang
    Gao, Zhibo
    Sun, Ying-Shi
    Li, Zhongwu
    Luo, Haitao
    Wu, Aiwen
    JAMA SURGERY, 2024, 159 (05) : 529 - 537
  • [42] PROshot: Weekly Cisplatin Versus Every-3-Weeks Cisplatin, Screening Spine Magnetic Resonance Imaging in Prostate Cancer, Total Neoadjuvant Therapy for Rectal Cancer, and Omitting the Elective Low Neck in Nasopharyngeal Cancer
    Dulaney, Caleb
    Dover, Laura
    PRACTICAL RADIATION ONCOLOGY, 2022, 12 (04) : 261 - 264
  • [43] Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease
    Stiles, Brendon M.
    Mirza, Farooq
    Coppolino, Anthony
    Port, Jeffrey L.
    Lee, Paul C.
    Paul, Subroto
    Altorki, Nasser K.
    ANNALS OF THORACIC SURGERY, 2011, 92 (02) : 491 - 498
  • [44] Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy?
    Sassen, S.
    de Booij, M.
    Sosef, M.
    Berendsen, R.
    Lammering, G.
    Clarijs, R.
    Bakker, M.
    Beets-Tan, R.
    Warmerdam, F.
    Vliegen, R.
    EUROPEAN RADIOLOGY, 2013, 23 (12) : 3440 - 3449
  • [45] Neoadjuvant therapy or upfront surgery? A systematic review and meta-analysis of T2N0 esophageal cancer treatment options
    Mota, F. C.
    Cecconello, I.
    Takeda, F. R.
    Tustumi, F.
    Sallum, R. A. A.
    Bernardo, W. M.
    INTERNATIONAL JOURNAL OF SURGERY, 2018, 54 : 176 - 181
  • [46] Single-agent epirubicin as primary chemotherapy in T2-T3, N0-N2, M0 breast carcinoma:: 6-year follow-up
    Barni, S
    Piazza, E
    Frontini, L
    Visini, M
    Ardizzoia, A
    Grassi, MM
    Nosenzo, MA
    Mandalà, M
    Biasioli, R
    Freddi, E
    Lucani, L
    Recalcati, A
    Pravettoni, A
    Sala, R
    Rezzani, C
    Villa, S
    Trabucchi, E
    ONCOLOGY, 2004, 67 (01) : 40 - 47
  • [47] Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601)
    Matsuyama, Jin
    Terazawa, Tetsuji
    Goto, Masahiro
    Kawabata, Ryohei
    Endo, Shunji
    Imano, Motohiro
    Fujita, Shoichiro
    Akamaru, Yusuke
    Taniguchi, Hirokazu
    Tatsumi, Mitsutoshi
    Lee, Sang-Woong
    Kawakami, Hisato
    Kurokawa, Yukinori
    Shimokawa, Toshio
    Sakai, Daisuke
    Kato, Takeshi
    Fujitani, Kazumasa
    Satoh, Taroh
    ONCOLOGIST, 2022, 27 (04) : 251 - +
  • [48] A Dynamic Clinical Calculator for Estimating Conditional Recurrence-Free Survival After Total Neoadjuvant Therapy for Rectal Cancer and Either Surgery or Watch-and-Wait Management
    Weiser, Martin R.
    Chou, Joanne F.
    Kim, Jin K.
    Widmar, Maria
    Wei, Iris H.
    Pappou, Emmanouil P.
    Smith, J. Joshua
    Nash, Garrett M.
    Paty, Philip B.
    Cercek, Andrea
    Saltz, Leonard B.
    Romesser, Paul B.
    Crane, Christopher H.
    Garcia-Aguilar, Julio
    Schrag, Deborah
    Gonen, Mithat
    JAMA NETWORK OPEN, 2022, 5 (09) : E2233859
  • [49] Local Excision After Preoperative Chemoradiation Results in an Equivalent Outcome to Total Mesorectal Excision in Selected Patients with T3 Rectal Cancer
    Callender, Glenda G.
    Das, Prajnan
    Rodriguez-Bigas, Miguel A.
    Skibber, John M.
    Crane, Christopher H.
    Krishnan, Sunil
    Delclos, Marc E.
    Feig, Barry W.
    ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (02) : 441 - 447
  • [50] Cost-Effectiveness of Total Neoadjuvant Therapy With Selective Nonoperative Management for Locally Advanced Rectal Cancer: Analysis of Data From the Organ Preservation for Rectal Adenocarcinoma Trial
    Widmar, Maria
    Mccain, Mason
    Meza, Akriti Mishra
    Ternent, Charles
    Briggs, Andrew
    Garcia-Aguilar, Julio
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (06)
12345